Edgestream Partners’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-610,632
Closed -$4.21M 508
2022
Q3
$4.21M Buy
+610,632
New +$4.24M 0.33% 103
2022
Q1
Sell
-60,346
Closed -$1.67M 530
2021
Q4
$1.67M Buy
60,346
+3,519
+6% +$94.2K 0.1% 255
2021
Q3
$1.58M Buy
+56,827
New +$1.61M 0.1% 271
2020
Q4
Sell
-118,459
Closed -$1.84M 361
2020
Q3
$1.84M Buy
+118,459
New +$2.04M 0.12% 189

Other funds holding BHC

Edgestream Partners's BHC Position: Q4 2022 in Review

Edgestream Partners sold out of Bausch Health (BHC) in Q4 2022, closing a stake of 610,632 shares — an estimated $4.21M sold.

Edgestream Partners first reported a position in BHC in Q3 2020 and held it in 4 quarters. The position peaked at $4.21M in Q3 2022. 262 funds tracked by Wall St. Rank hold BHC as of Q4 2022.

  • Edgestream Partners reported no remaining Bausch Health position as of Q4 2022 after selling out during the quarter.
  • Edgestream Partners sold 610,632 Bausch Health shares in Q4 2022, an estimated $4.21M.
  • Edgestream Partners first reported a position in Bausch Health in Q3 2020 and held it in 4 quarters.
  • Edgestream Partners's Bausch Health position peaked at $4.21M in Q3 2022.
  • 262 funds tracked by Wall St. Rank held Bausch Health as of Q4 2022.

Based on Edgestream Partners's 13F filing for Q4 2022, filed 13 Feb 2023.